JSP Pharmaceutical Manufacturing (Thailand) Public Balance Sheet Health
Financial Health criteria checks 5/6
JSP Pharmaceutical Manufacturing (Thailand) Public has a total shareholder equity of THB930.5M and total debt of THB154.5M, which brings its debt-to-equity ratio to 16.6%. Its total assets and total liabilities are THB1.3B and THB405.2M respectively. JSP Pharmaceutical Manufacturing (Thailand) Public's EBIT is THB658.3K making its interest coverage ratio 0.1. It has cash and short-term investments of THB20.7M.
Key information
16.6%
Debt to equity ratio
฿154.50m
Debt
Interest coverage ratio | 0.05x |
Cash | ฿20.65m |
Equity | ฿930.50m |
Total liabilities | ฿405.17m |
Total assets | ฿1.34b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: JSP's short term assets (THB245.6M) exceed its short term liabilities (THB194.8M).
Long Term Liabilities: JSP's short term assets (THB245.6M) exceed its long term liabilities (THB210.4M).
Debt to Equity History and Analysis
Debt Level: JSP's net debt to equity ratio (14.4%) is considered satisfactory.
Reducing Debt: JSP's debt to equity ratio has reduced from 213.4% to 16.6% over the past 5 years.
Debt Coverage: JSP's debt is well covered by operating cash flow (26.1%).
Interest Coverage: JSP's interest payments on its debt are not well covered by EBIT (0.1x coverage).